CFRX
Closed
Contrafect Corp
0.0271
-0.0054 (-16.62%)
Last Update: 07 Feb 2024 17:30:00
Yesterday: 0.0325
Day's Range: 0.0271 - 0.0325
Send
sign up or login to leave a comment!
When Written:
1.83
ContraFect Corp is a biotechnology company that develops and commercializes novel therapeutic products for the treatment of life-threatening infectious diseases. The company's proprietary technology platform, called lysin therapy, is based on the use of naturally occurring bacteriophage lysins to target and eliminate specific bacteria. ContraFect's lead product candidate, CF-301, is a lysin therapy designed to treat Staphylococcus aureus bloodstream infections. The company is also developing lysin therapies for the treatment of other bacterial infections, including pneumonia, urinary tract infections, and wound infections. ContraFect is headquartered in Yonkers, New York, and trades on the NASDAQ under the ticker symbol CFRX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








